UNLABELLED: Primary ciliary dyskinesia (PCD) is a rare autosomal recessive disease, caused by specific primary structural and/or functional abnormalities of the motile cilia, in contrast with the transitory abnormalities seen in secondary ciliary dyskinesia. Disease-causing mutations in at least 16 genes have already been identified. The true incidence of PCD may be higher than currently reported, because the diagnosis is challenging and often missed. For the confirmation of PCD, both ciliary motility as well as ciliary ultrastructure must be evaluated. An early and adequate diagnosis and therapy can theoretically prevent bronchiectasis. Measurement of nasal nitric oxide has some value as a screening test but cannot be performed in young children. In the respiratory tract epithelium, impaired mucociliary clearance leads to chronic and/or recurrent upper and lower respiratory tract infections. In up to 75 % of the patients, respiratory manifestations start in the newborn period, although the diagnosis is often missed at that time. During embryogenesis, nodal cilia, which are motile cilia, determine the correct lateralization of the organs. Dysfunction of these cilia leads to random lateralization and thus situs inversus in approximately 50 % of the patients with PCD. The tail of a spermatozoon has a structure similar to that of a motile cilium. Consequently, male infertility due to immotile spermatozoa is often part of the characteristics of PCD. Given the heterogeneity and the rarity of the disorder, therapy is not evidence-based. Many treatment schedules are proposed in analogy with the treatment for cystic fibrosis. CONCLUSION: Respiratory infections, situs inversus and male infertility are typical manifestations of PCD, a rare autosomal recessive disorder.
UNLABELLED: Primary ciliary dyskinesia (PCD) is a rare autosomal recessive disease, caused by specific primary structural and/or functional abnormalities of the motile cilia, in contrast with the transitory abnormalities seen in secondary ciliary dyskinesia. Disease-causing mutations in at least 16 genes have already been identified. The true incidence of PCD may be higher than currently reported, because the diagnosis is challenging and often missed. For the confirmation of PCD, both ciliary motility as well as ciliary ultrastructure must be evaluated. An early and adequate diagnosis and therapy can theoretically prevent bronchiectasis. Measurement of nasal nitric oxide has some value as a screening test but cannot be performed in young children. In the respiratory tract epithelium, impaired mucociliary clearance leads to chronic and/or recurrent upper and lower respiratory tract infections. In up to 75 % of the patients, respiratory manifestations start in the newborn period, although the diagnosis is often missed at that time. During embryogenesis, nodal cilia, which are motile cilia, determine the correct lateralization of the organs. Dysfunction of these cilia leads to random lateralization and thus situs inversus in approximately 50 % of the patients with PCD. The tail of a spermatozoon has a structure similar to that of a motile cilium. Consequently, male infertility due to immotile spermatozoa is often part of the characteristics of PCD. Given the heterogeneity and the rarity of the disorder, therapy is not evidence-based. Many treatment schedules are proposed in analogy with the treatment for cystic fibrosis. CONCLUSION:Respiratory infections, situs inversus and male infertility are typical manifestations of PCD, a rare autosomal recessive disorder.
Authors: Marie-Pierre F Strippoli; Thomas Frischer; Angelo Barbato; Deborah Snijders; Elisabeth Maurer; Jane S A Lucas; Ernst Eber; Bulent Karadag; Petr Pohunek; Zorica Zivkovic; Amparo Escribano; Chris O'Callaghan; Andrew Bush; Claudia E Kuehni Journal: Eur Respir J Date: 2012-01-26 Impact factor: 16.671
Authors: M Pifferi; A Bush; D Caramella; M Di Cicco; M Zangani; I Chinellato; P Macchia; A L Boner Journal: Eur Respir J Date: 2010-07-22 Impact factor: 16.671
Authors: Anne-Christine Merveille; Erica E Davis; Anita Becker-Heck; Marie Legendre; Israel Amirav; Géraldine Bataille; John Belmont; Nicole Beydon; Frédéric Billen; Annick Clément; Cécile Clercx; André Coste; Rachelle Crosbie; Jacques de Blic; Stephane Deleuze; Philippe Duquesnoy; Denise Escalier; Estelle Escudier; Manfred Fliegauf; Judith Horvath; Kent Hill; Mark Jorissen; Jocelyne Just; Andreas Kispert; Mark Lathrop; Niki Tomas Loges; June K Marthin; Yukihide Momozawa; Guy Montantin; Kim G Nielsen; Heike Olbrich; Jean-François Papon; Isabelle Rayet; Gilles Roger; Miriam Schmidts; Henrique Tenreiro; Jeffrey A Towbin; Diana Zelenika; Hanswalter Zentgraf; Michel Georges; Anne-Sophie Lequarré; Nicholas Katsanis; Heymut Omran; Serge Amselem Journal: Nat Genet Date: 2010-12-05 Impact factor: 38.330
Authors: M Failly; L Bartoloni; A Letourneau; A Munoz; E Falconnet; C Rossier; M M de Santi; F Santamaria; O Sacco; C D DeLozier-Blanchet; R Lazor; J-L Blouin Journal: J Med Genet Date: 2009-04 Impact factor: 6.318
Authors: Georg C Schwabe; Katrin Hoffmann; Niki Tomas Loges; Daniel Birker; Colette Rossier; Margherita M de Santi; Heike Olbrich; Manfred Fliegauf; Mike Failly; Uta Liebers; Mirella Collura; Gerhard Gaedicke; Stefan Mundlos; Ulrich Wahn; Jean-Louis Blouin; Bodo Niggemann; Heymut Omran; Stylianos E Antonarakis; Lucia Bartoloni Journal: Hum Mutat Date: 2008-02 Impact factor: 4.878
Authors: Kieran Brune; James Frank; Andreas Schwingshackl; James Finigan; Venkataramana K Sidhaye Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-01-30 Impact factor: 5.464
Authors: Panayiotis Kouis; Panayiotis K Yiallouros; Nicos Middleton; John S Evans; Kyriacos Kyriacou; Stefania I Papatheodorou Journal: Pediatr Res Date: 2016-12-09 Impact factor: 3.756